{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:57:38Z","timestamp":1790017058731,"version":"4.0.1"},"reference-count":61,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Hum. Neurosci."],"abstract":"<jats:p>Bipolar disorder (BD) is a chronic and debilitating mental illness affecting approximately 40 million people worldwide. Cognitive impairment is a core feature of BD, impacting daily functioning and persisting even during mood stability. Cognitive deficits are among the most reliable indicators of long-term functional outcomes in BD. Despite their significance, there are currently no widely available treatments targeting cognitive impairment in BD, largely due to our limited understanding of the underlying pathophysiology. A healthy blood\u2013brain barrier (BBB) is essential for brain homeostasis, serving as a protective filter that restricts peripheral toxins, pathogens, and ions from entering the brain and disrupting neuronal function. Increased BBB permeability can allow harmful substances to infiltrate the brain, potentially leading to neuroinflammation, disrupted signaling, and damage to brain tissue, all of which may contribute to cognitive impairments in BD. Thus, BBB dysfunction could represent an upstream driver of cognitive impairment in BD, offering a potential target for disease-modifying interventions. This narrative review examined the evidence for the link between BBB permeability and cognitive deficits in BD. Our search yielded limited studies with mixed findings, highlighting the significant need for further research to explore this critical area and its potential for developing disease-modifying treatments.<\/jats:p>","DOI":"10.3389\/fnhum.2025.1504575","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:48:36Z","timestamp":1739947716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["The role of blood\u2013brain barrier dysfunction in cognitive impairments in bipolar disorder\u2014a narrative review"],"prefix":"10.3389","volume":"19","author":[{"given":"Caitlin E.","family":"Millett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faria","family":"Monir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pina","family":"Sanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1093\/brain\/awv266","article-title":"Manic episodes are related to changes in frontal cortex: a longitudinal neuroimaging study of bipolar disorder 1","volume":"138","author":"Ab\u00e9","year":"2015","journal-title":"Brain"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1038\/s41380-023-02073-4","article-title":"Mania-related effects on structural brain changes in bipolar disorder \u2013 a narrative review of the evidence","volume":"28","author":"Ab\u00e9","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.jpsychires.2006.07.013","article-title":"Serum S100B and antioxidant enzymes in bipolar patients","volume":"41","author":"Andreazza","year":"2007","journal-title":"J. Psychiatr. Res."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12987-017-0063-4","article-title":"Barrier dysfunction or drainage reduction: differentiating causes of CSF protein increase","volume":"14","author":"Asgari","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1017\/S0033291717001490","article-title":"Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia","volume":"47","author":"Bora","year":"2017","journal-title":"Psychol. Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1093\/schbul\/sbu198","article-title":"Meta-analysis of cognitive impairment in first-episode bipolar disorder: comparison with first-episode schizophrenia and healthy controls","volume":"41","author":"Bora","year":"2015","journal-title":"Schizophr. Bull"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4088\/JCP.11m07299","article-title":"Placebo-controlled adjunctive trial of pramipexole in patients with bipolar disorder: targeting cognitive dysfunction","volume":"73","author":"Burdick","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/npp.2011.36","article-title":"The MATRICS consensus cognitive battery in patients with bipolar I disorder","volume":"36","author":"Burdick","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.euroneuro.2021.06.008","article-title":"Cognitive heterogeneity is a key predictor of differential functional outcome in patients with bipolar disorder","volume":"53","author":"Burdick","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/bdi.13208","article-title":"Predictors of functional impairment in bipolar disorder: results from 13 cohorts from seven countries by the global bipolar cohort collaborative","volume":"24","author":"Burdick","year":"2022","journal-title":"Bipolar Disord."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1017\/s0033291714000439","article-title":"Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications","volume":"44","author":"Burdick","year":"2014","journal-title":"Psychol. Med."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.bpsc.2022.06.006","article-title":"Increased blood-brain barrier permeability of the thalamus correlated with symptom severity and brain volume alterations in patients with schizophrenia","volume":"7","author":"Cheng","year":"2022","journal-title":"Biol. Psychiatr. Cogn. Neurosci. Neuroimaging."},{"key":"ref13","volume-title":"CANTAB, cognitive assessment software. All right reserved","author":"Cognition","year":"2018"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jad.2015.11.007","article-title":"Executive function impairments in depression and bipolar disorder: association with functional impairment and quality of life","volume":"190","author":"Cotrena","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.2044-8260.1987.tb01366.x","article-title":"Estimation of premorbid intellectual status in depression","volume":"26","author":"Crawford","year":"1987","journal-title":"Br. J. Clin. Psychol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jad.2016.07.030","article-title":"Serum S100B in manic bipolar disorder patients: systematic review and meta-analysis","volume":"206","author":"da Rosa","year":"2016","journal-title":"J. Affect. Disord."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1399-5618.2012.01011.x","article-title":"Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder","volume":"14","author":"Depp","year":"2012","journal-title":"Bipolar Disord."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S2215-0366(16)30370-4","article-title":"C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis","volume":"3","author":"Fernandes","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jamapsychiatry.2019.3993","article-title":"Long-term changes in cognitive functioning in individuals with psychotic disorders: findings from the Suffolk County mental health project","volume":"77","author":"Fett","year":"2020","journal-title":"JAMA Psychiatr."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"100102","DOI":"10.1016\/j.bbih.2020.100102","article-title":"Blood-brain barrier pathology in patients with severe mental disorders: A systematic review and meta-analysis of biomarkers in case-control studies","volume":"6","author":"Futtrup","year":"2020","journal-title":"Brain Behav. Immun. Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1248\/bpb.b21-00408","article-title":"Claudin-5: a pharmacological target to modify the permeability of the blood-brain barrier","volume":"44","author":"Hashimoto","year":"2021","journal-title":"Biol. Pharm. Bull."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.bpsc.2022.09.017","article-title":"Glutamatergic Neurometabolite levels in bipolar disorder: a systematic review and Meta-analysis of proton magnetic resonance spectroscopy studies","volume":"8","author":"Ino","year":"2023","journal-title":"Biol. Psychiatr. Cogn. Neurosci. Neuroimaging"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2214\/AJR.17.18237","article-title":"Blood-brain barrier permeability in aneurysmal subarachnoid hemorrhage: correlation with clinical outcomes","volume":"211","author":"Ivanidze","year":"2018","journal-title":"AJR"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/jamapsychiatry.2022.1142","article-title":"The course of general cognitive ability in individuals with psychotic disorders","volume":"79","author":"Jonas","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"102049","DOI":"10.1016\/j.nicl.2019.102049","article-title":"Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression","volume":"26","author":"Kamintsky","year":"2019","journal-title":"NeuroImage: Clinical"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s40345-023-00324-5","article-title":"Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case\u2013control study of patients with bipolar disorder and healthy control individuals","volume":"12","author":"Knorr","year":"2024","journal-title":"Int. J. Bipolar Disord."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1192\/bjp.2023.127","article-title":"Mapping the global, regional and national burden of bipolar disorder from 1990 to 2019: trend analysis on the global burden of disease study 2019","volume":"224","author":"Lai","year":"2024","journal-title":"Br. J. Psychiatr."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1111\/bdi.12904","article-title":"Functioning in euthymic patients with bipolar disorder: a systematic review and meta-analysis using the functioning assessment short test","volume":"22","author":"L\u00e9da-R\u00eago","year":"2020","journal-title":"Bipolar Disord."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.lfs.2004.07.021","article-title":"Increased cerebrospinal fluid levels of S100B protein in rat model of mania induced by ouabain","volume":"76","author":"Machado-Vieira","year":"2004","journal-title":"Life Sci."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3810\/pgm.2010.07.2170","article-title":"Cognitive impairment in bipolar disorder: an overview","volume":"122","author":"Manove","year":"2010","journal-title":"Postgrad. Med."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/jnc.14574","article-title":"The S100B story: from biomarker to active factor in neural injury","volume":"148","author":"Michetti","year":"2019","journal-title":"J. Neurochem."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/HRP.0000000000000297","article-title":"Defining heterogeneous cognitive trajectories in bipolar disorder: a perspective","volume":"29","author":"Millett","year":"2021","journal-title":"Harv. Rev. Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1111\/bdi.12595","article-title":"Assessing and addressing cognitive impairment in bipolar disorder: the international society for bipolar disorders targeting cognition task force recommendations for clinicians","volume":"20","author":"Miskowiak","year":"2018","journal-title":"Bipolar Disord."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/bdi.12534","article-title":"Methodological recommendations for cognition trials in bipolar disorder by the international society for bipolar disorders targeting cognition task force","volume":"19","author":"Miskowiak","year":"2017","journal-title":"Bipolar Disord."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jad.2021.10.044","article-title":"Associations between cognition and subsequent mood episodes in patients with bipolar disorder and their unaffected relatives: a systematic review","volume":"297","author":"Miskowiak","year":"2022","journal-title":"J. Affect. Disord."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"e1639","DOI":"10.4088\/JCP.15m10480","article-title":"Targeting treatments to improve cognitive function in mood disorder: suggestions from trials using erythropoietin","volume":"77","author":"Miskowiak","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"23299782","DOI":"10.1101\/2023.12.12.23299782v1","article-title":"Increased blood\u2013brain barrier leakage in schizophrenia spectrum disorders compared to healthy controls in dynamic contrast-enhanced magnetic resonance imaging","volume":"12","author":"Moussiopoulou","year":"2023","journal-title":"medRxiv"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1742-2094-10-142","article-title":"Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jad.2020.05.015","article-title":"S100B and brain derived neurotrophic factor in monozygotic twins with, at risk of and without affective disorders","volume":"274","author":"Ottesen","year":"2020","journal-title":"J. Affect. Disord."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/alz.13433","article-title":"Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: a longitudinal study in a memory unit clinical cohort","volume":"20","author":"Puig-Pijoan","year":"2024","journal-title":"Alzheimer\u2019s Dementia"},{"key":"ref42","volume-title":"Screen for cognitive impairment in psychiatry: Administration and psychometric properties","author":"Purdon","year":"2005"},{"key":"ref43","volume-title":"RBANS manual: Repeatable battery for the assessment of neuropsychological status","author":"Randolph","year":"1998"},{"key":"ref44","first-page":"286","article-title":"Psychological examination of traumatic encephalopathy","volume":"7","author":"Rey","year":"1941","journal-title":"Archieves Psychol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1017\/S0033291721004517","article-title":"The long-term course of cognition in bipolar disorder: a systematic review and meta-analysis of patient-control differences in test-score changes","volume":"52","author":"Samam\u00e9","year":"2022","journal-title":"Psychol. Med."},{"key":"ref46","volume-title":"Rey auditory verbal learning test: RAVLT: A handbook","author":"Schmidt","year":"1996"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/ijnp\/pyx032","article-title":"Cognitive impairment in bipolar disorder: treatment and prevention strategies","volume":"20","author":"Sol\u00e9","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/jcbfm.2012.25","article-title":"Pathophysiology of the neurovascular unit: disease cause or consequence?","volume":"32","author":"Stanimirovic","year":"2012","journal-title":"J. Cerebral Blood Flow Metab."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood\u2013brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1176\/appi.ajp.162.10.1904","article-title":"Premorbid intellectual functioning in bipolar disorder and schizophrenia: results from a cohort study of male conscripts","volume":"162","author":"Tiihonen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jad.2018.08.040","article-title":"Cerebral blood flow in bipolar disorder: A systematic review","volume":"241","author":"Toma","year":"2018","journal-title":"J. Aff. Disorders"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.comppsych.2016.12.008","article-title":"Decreased S100B serum levels after treatment in bipolar patients in a manic phase","volume":"74","author":"Tsai","year":"2017","journal-title":"Compr. Psychiatry"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/bdi.12821","article-title":"Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: an overview of evidence","volume":"22","author":"Van Rheenen","year":"2020","journal-title":"Bipolar Disord"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"acps.13153","DOI":"10.1111\/acps.13153","article-title":"Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses","volume":"2020","author":"Velosa","year":"2020","journal-title":"Acta Psychiatr. Scand."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jad.2024.06.032","article-title":"The blood-brain barrier in bipolar disorders: a systematic review","volume":"361","author":"Wakonigg Alonso","year":"2024","journal-title":"J. Affect. Disord."},{"key":"ref57","volume-title":"Wechsler Adult Intelligence Scale III","author":"Wechsler","year":"1997"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"870674","DOI":"10.3389\/fncel.2022.870674","article-title":"Blood\u2013brain barrier dysfunction and the potential mechanisms in chronic cerebral Hypoperfusion induced cognitive impairment","volume":"16","author":"Xu","year":"2022","journal-title":"Front. Cell Neurosci."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1007\/s00406-023-01726-3","article-title":"The common misconception of blood-brain barrier terminology in psychiatry and neurology","volume":"274","author":"Yakimov","year":"2024","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1001\/archpsyc.61.4.354","article-title":"A longitudinal study of premorbid IQ score and risk of developing schizophrenia, bipolar disorder, severe depression, and other nonaffective psychoses","volume":"61","author":"Zammit","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.psychres.2014.03.045","article-title":"Blood\u2013cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment","volume":"217","author":"Zetterberg","year":"2014","journal-title":"Psychiatry Res."}],"container-title":["Frontiers in Human Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1504575\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T06:48:40Z","timestamp":1739947720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnhum.2025.1504575\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":61,"alternative-id":["10.3389\/fnhum.2025.1504575"],"URL":"https:\/\/doi.org\/10.3389\/fnhum.2025.1504575","relation":{},"ISSN":["1662-5161"],"issn-type":[{"value":"1662-5161","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"article-number":"1504575"}}